Moroctocog alfa
ReFacto AF (moroctocog alfa) is a protein pharmaceutical. Moroctocog alfa was first approved as ReFacto AF on 1999-04-13. It has been approved in Europe to treat hemophilia a.
| Trade Name | ReFacto AF |
|---|---|
| Common Name | Moroctocog alfa |
| Indication | hemophilia a |
| Drug Class |
